Back

Title: Cell-autonomous and non-cell-autonomous effects of TRIM72 on ALS disease progression

Jia, Y.; Fan, D.; Zhang, X.; He, J.; Song, N.; Li, X.; Wang, W. X.; Hu, Y.; Li, Q.; Hu, Y.; Yin, C.; Zhao, P.; Jiang, X.; Piao, X.; Meng, D.; Cheng, H.; Chen, Z.; Huang, X.; Yu, P.; Qi, X.; Ren, J.; Luo, L.; Peng, L.; Guo, W.; Wang, T.; Gong, H.

2025-01-13 neuroscience
10.1101/2025.01.09.632080 bioRxiv
Show abstract

Dysfunction of RNA-binding proteins, including TDP-43 and FUS, has been associated with amyotrophic lateral sclerosis (ALS); however, the underlying mechanisms are largely unknown. Here, we reported that a neuronal upregulation of TRIM72 (Tripartite Motif Containing 72) in FUS mutation knockin ALS models slows disease progression. TRIM72 interacts with Commander, a protein complex for recycling of membrane proteins, facilitating membrane repair and antioxidation. Exosomal TRIM72 is detected in ALS patient cerebrospinal fluid (CSF) and extracellular application of exosomal TRIM72 protects cell from membrane damage. In a sporadic ALS cohort, CSF TRIM72 level associates ALS disease progression. AAV-mediated neuronal expression of TRIM72 slows down the disease progressions in ALS models and in an ALS patient without adverse effects over a year treatment course. Taken together, our results suggest a universal neuronal protection of a TRIM family protein in cell-autonomous and non-cell-autonomous manners in ALS.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.